Director/PDMR Shareholding

1 May 2014

Directors' Dealings

Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 30 April 2014 that earlier that day Chris Spooner, the Chief Executive Officer, acquired 285,844 ordinary shares in Sinclair and Julie Spooner, spouse of Chris Spooner, acquired 57,627 ordinary shares in Sinclair. The purchases were made at an average price of 30.875p per share. Following this purchase Chris Spooner has a beneficial interest in 8,750,734 ordinary shares representing 2.01% of the Group's issued ordinary share capital.

Sinclair was also informed on 30 April that Stuart Swanson, a Non-Executive Director, acquired 12,774 ordinary shares in Sinclair at a price of 30.5p per share. Following this purchase Stuart Swanson has a beneficial interest in 4,535,628 ordinary shares representing 1.04% of the Group's issued ordinary share capital. For the avoidance of doubt this holding excludes the 3,125,000 Placing Shares that Stuart Swanson is subscribing for as part of the Placing announced on 15 April 2014 which is due to complete on 2 May 2014. 

For further information, please contact:

Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920

Chris Spooner

Alan Olby

Robert Taylor

Peel Hunt LLP Tel: +44 (0) 20 7418 8900

James Steel

Clare Terlouw